ALDX
#3969
Aldeyra Therapeutics, Inc. - Common Stock
1.4 9 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.68%
Changement Mensuel
-3.87%
Evolution sur 6 mois
-72.96%
Changement Annuel
-73.81%
Clôture Précédente
1.4 8
Open
1.4 9
Low
1.4 9
High
1.4 9
Volume
21
Financials
- Market Capitalization 89.89 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.61
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3966 |  ICCC ImmuCell Corporation - Common Stock | 9.92 USD | +1.33% | +0.71% | -12.44% | +52.15% | 90.10 M USD | ||
| 3967 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.24 USD | -4.03% | +7.82% | +0.38% | -12.96% | 90.02 M USD | ||
| 3976 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.68 USD | -2.19% | -3.94% | -7.59% | -11.84% | 89.38 M USD | ||
| 3980 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.07 USD | -0.96% | -4.61% | +36.18% | +55.64% | 88.71 M USD |